skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 2,099  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
2 Delaying the development of type 1 diabetes
Material Type:
Article
Add to My Research

2 Delaying the development of type 1 diabetes

BMJ paediatrics open, 2024-05, Vol.8 (Suppl 4), p.A1-A1 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2399-9772 ;DOI: 10.1136/bmjpo-2024-ASPED.2

Digital Resources/Online E-Resources

2
7 Screening for type 1 diabetes
Material Type:
Article
Add to My Research

7 Screening for type 1 diabetes

BMJ paediatrics open, 2024-05, Vol.8 (Suppl 4), p.A2-A3 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2399-9772 ;DOI: 10.1136/bmjpo-2024-ASPED.7

Digital Resources/Online E-Resources

3
703 Pervasive sharing of causal genetic risk factors contributes to clinical and molecular overlap between Sjögren’s Disease and SLE
Material Type:
Article
Add to My Research

703 Pervasive sharing of causal genetic risk factors contributes to clinical and molecular overlap between Sjögren’s Disease and SLE

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A62-A63 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-lupus21century.54

Full text available

4
Analgesia for the treatment of acute pancreatitis: a protocol for a systematic review and network meta-analysis
Material Type:
Article
Add to My Research

Analgesia for the treatment of acute pancreatitis: a protocol for a systematic review and network meta-analysis

BMJ open, 2024-05, Vol.14 (5), p.e081971-e081971 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-081971 ;PMID: 38740508

Full text available

5
Polygenic risk score: the potential role in the management of systemic lupus erythematosus
Material Type:
Article
Add to My Research

Polygenic risk score: the potential role in the management of systemic lupus erythematosus

Rheumatic & musculoskeletal diseases open, 2024-05, Vol.10 (2), p.e004156 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2056-5933 ;DOI: 10.1136/rmdopen-2024-004156 ;PMID: 38702063

Full text available

6
Shared genetic architecture highlights the bidirectional association between major depressive disorder and fracture risk
Material Type:
Article
Add to My Research

Shared genetic architecture highlights the bidirectional association between major depressive disorder and fracture risk

General psychiatry, 2024-05, Vol.37 (3), p.e101418-e101418 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2517-729X ;ISSN: 2096-5923 ;EISSN: 2517-729X ;DOI: 10.1136/gpsych-2023-101418 ;PMID: 38737893

Full text available

7
Associations of combined phenotypic aging and genetic risk with incident cancer: A prospective cohort study
Material Type:
Article
Add to My Research

Associations of combined phenotypic aging and genetic risk with incident cancer: A prospective cohort study

eLife, 2024-04, Vol.13 [Peer Reviewed Journal]

2024, Bian, Ma et al. ;2024, Bian, Ma et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024, Bian, Ma et al 2024 Bian, Ma et al ;EISSN: 2050-084X ;DOI: 10.7554/eLife.91101 ;PMID: 38687190

Full text available

8
Study protocol to assess aflatoxin M1 health risks versus benefits of dairy consumption in Ethiopian children: an epidemiological trial and risk-benefit analysis
Material Type:
Article
Add to My Research

Study protocol to assess aflatoxin M1 health risks versus benefits of dairy consumption in Ethiopian children: an epidemiological trial and risk-benefit analysis

BMJ open, 2024-04, Vol.14 (4), p.e084257-e084257 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2024-084257 ;PMID: 38684249

Full text available

9
Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial
Material Type:
Article
Add to My Research

Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial

BMJ open, 2024-04, Vol.14 (4), p.e082047-e082047 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-082047 ;PMID: 38670614

Full text available

10
Sleep and circadian biomarkers of postoperative delirium (SLEEP-POD): protocol for a prospective and observational cohort study
Material Type:
Article
Add to My Research

Sleep and circadian biomarkers of postoperative delirium (SLEEP-POD): protocol for a prospective and observational cohort study

BMJ open, 2024-04, Vol.14 (4), p.e080796-e080796 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-080796 ;PMID: 38643014

Full text available

11
Genetic risk of type 2 diabetes modifies the association between lifestyle and glycemic health at 5 years postpartum among high-risk women
Material Type:
Article
Add to My Research

Genetic risk of type 2 diabetes modifies the association between lifestyle and glycemic health at 5 years postpartum among high-risk women

BMJ open diabetes research & care, 2024-04, Vol.12 (2), p.e003942 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2052-4897 ;DOI: 10.1136/bmjdrc-2023-003942 ;PMID: 38631819

Full text available

12
Impact of health education on promoting influenza vaccination health literacy in primary school students: a cluster randomised controlled trial protocol
Material Type:
Article
Add to My Research

Impact of health education on promoting influenza vaccination health literacy in primary school students: a cluster randomised controlled trial protocol

BMJ open, 2024-04, Vol.14 (4), p.e080115-e080115 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-080115 ;PMID: 38609315

Full text available

13
Deciphering the complex relationship between type 2 diabetes and fracture risk with both genetic and observational evidence
Material Type:
Article
Add to My Research

Deciphering the complex relationship between type 2 diabetes and fracture risk with both genetic and observational evidence

eLife, 2024-04, Vol.12 [Peer Reviewed Journal]

2023, Zhao, Sheng, Xu et al. ;2023, Zhao, Sheng, Xu et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023, Zhao, Sheng, Xu et al 2023 Zhao, Sheng, Xu et al ;EISSN: 2050-084X ;DOI: 10.7554/eLife.89281 ;PMID: 38591545

Full text available

14
Single-cell 'omic profiles of human aortic endothelial cells in vitro and human atherosclerotic lesions ex vivo reveal heterogeneity of endothelial subtype and response to activating perturbations
Material Type:
Article
Add to My Research

Single-cell 'omic profiles of human aortic endothelial cells in vitro and human atherosclerotic lesions ex vivo reveal heterogeneity of endothelial subtype and response to activating perturbations

eLife, 2024-04, Vol.12 [Peer Reviewed Journal]

2023, Adelus et al. ;2023, Adelus et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2050-084X ;DOI: 10.7554/eLife.91729 ;PMID: 38578680

Full text available

15
Longitudinal observational cohort study: Speech for Intelligent cognition change tracking and DEtection of Alzheimer’s Disease (SIDE-AD)
Material Type:
Article
Add to My Research

Longitudinal observational cohort study: Speech for Intelligent cognition change tracking and DEtection of Alzheimer’s Disease (SIDE-AD)

BMJ open, 2024-03, Vol.14 (3), p.e082388-e082388 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-082388 ;PMID: 38548356

Full text available

16
Health risks of exposure to air pollution in areas where coal-fired power plants are located: protocol for a scoping review
Material Type:
Article
Add to My Research

Health risks of exposure to air pollution in areas where coal-fired power plants are located: protocol for a scoping review

BMJ open, 2024-03, Vol.14 (3), p.e084074-e084074 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2024-084074 ;PMID: 38508645

Full text available

17
Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer’s disease (DEBBIE-AD): a prospective observational multicohort study protocol
Material Type:
Article
Add to My Research

Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer’s disease (DEBBIE-AD): a prospective observational multicohort study protocol

BMJ open, 2024-03, Vol.14 (3), p.e081635-e081635 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-081635 ;PMID: 38458785

Full text available

18
Personalized Drug Therapy: Innovative Concept Guided With Proteoformics
Material Type:
Article
Add to My Research

Personalized Drug Therapy: Innovative Concept Guided With Proteoformics

Molecular & cellular proteomics, 2024-03, Vol.23 (3), p.100737-100737, Article 100737 [Peer Reviewed Journal]

2024 The Authors ;Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. ;2024 The Authors 2024 ;ISSN: 1535-9476 ;EISSN: 1535-9484 ;DOI: 10.1016/j.mcpro.2024.100737 ;PMID: 38354979

Full text available

19
Evaluating pharmacological THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment across NHS and private clinics in the UK: a multi-centre, assessor-blind, randomised controlled trial—THRIVE trial
Material Type:
Article
Add to My Research

Evaluating pharmacological THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment across NHS and private clinics in the UK: a multi-centre, assessor-blind, randomised controlled trial—THRIVE trial

BMJ open, 2024-02, Vol.14 (2), p.e083488-e083488 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-083488 ;PMID: 38367965

Full text available

20
Characterization of caffeine response regulatory variants in vascular endothelial cells
Material Type:
Article
Add to My Research

Characterization of caffeine response regulatory variants in vascular endothelial cells

eLife, 2024-02, Vol.13 [Peer Reviewed Journal]

2024, Boye et al. ;2024, Boye et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024, Boye et al 2024 Boye et al ;EISSN: 2050-084X ;DOI: 10.7554/eLife.85235 ;PMID: 38334359

Full text available

Results 1 - 20 of 2,099  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (2,096)

Refine My Results

Creation Date 

From To
  1. Before 2003  (29)
  2. 2003 To 2009  (50)
  3. 2010 To 2014  (183)
  4. 2015 To 2020  (1,644)
  5. After 2020  (194)
  6. More options open sub menu

Resource Type 

  1. Articles  (2,095)
  2. Conference Proceedings  (4)
  3. More options open sub menu

Language 

  1. Japanese  (167)
  2. Norwegian  (14)
  3. French  (3)
  4. More options open sub menu

Searching Remote Databases, Please Wait